Literature DB >> 23604134

Clinical measures for increased creatinine clearances and suboptimal antibiotic dosing.

Mathias W Pletz, Jeffrey Lipman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23604134     DOI： 10.1007/s00134-013-2918-8

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  18 in total

1.  Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumonia.

Authors:  Antonio T Freire; Vasyl Melnyk; Min Ja Kim; Oleksiy Datsenko; Oleksandr Dzyublik; Felix Glumcher; Yin-Ching Chuang; Robert T Maroko; Gary Dukart; C Angel Cooper; Joan M Korth-Bradley; Nathalie Dartois; Hassan Gandjini
Journal:  Diagn Microbiol Infect Dis       Date:  2010-10       Impact factor: 2.803

2.  Underdosing of ertapenem in critically ill patients with pneumonia confirmed by Monte Carlo simulations.

Authors:  Olaf Burkhardt; Vipul Kumar; Stephan Schmidt; Jan T Kielstein; Tobias Welte; Hartmut Derendorf
Journal:  Int J Antimicrob Agents       Date:  2009-11-06       Impact factor: 5.283

3.  Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists.

Authors:  Michael J Rybak; Ben M Lomaestro; John C Rotschafer; Robert C Moellering; Willam A Craig; Marianne Billeter; Joseph R Dalovisio; Donald P Levine
Journal:  Clin Infect Dis       Date:  2009-08-01       Impact factor: 9.079

4.  Pitfalls of using estimations of glomerular filtration rate in an intensive care population.

Authors:  J H Martin; M F Fay; A Udy; J Roberts; C Kirkpatrick; J Ungerer; J Lipman
Journal:  Intern Med J       Date:  2011-07       Impact factor: 2.048

5.  Subtherapeutic initial β-lactam concentrations in select critically ill patients: association between augmented renal clearance and low trough drug concentrations.

Authors:  Andrew A Udy; Julie M Varghese; Mahdi Altukroni; Scott Briscoe; Brett C McWhinney; Jacobus P Ungerer; Jeffrey Lipman; Jason A Roberts
Journal:  Chest       Date:  2012-07       Impact factor: 9.410

6.  Optimization of meropenem dosage in the critically ill population based on renal function.

Authors:  Jared L Crandon; Robert E Ariano; Sheryl A Zelenitsky; Anthony M Nicasio; Joseph L Kuti; David P Nicolau
Journal:  Intensive Care Med       Date:  2010-12-07       Impact factor: 17.440

7.  Relationship between the MIC of vancomycin and clinical outcome in patients with MRSA nosocomial pneumonia.

Authors:  Eun Young Choi; Jin Won Huh; Chae-Man Lim; Younsuck Koh; Sung-Han Kim; Sang-Ho Choi; Yang Soo Kim; Mi-Na Kim; Sang-Bum Hong
Journal:  Intensive Care Med       Date:  2011-01-21       Impact factor: 17.440

8.  Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections.

Authors:  Pamela A Moise-Broder; Alan Forrest; Mary C Birmingham; Jerome J Schentag
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

9.  Vancomycin dosing in critically ill patients: robust methods for improved continuous-infusion regimens.

Authors:  Jason A Roberts; Fabio Silvio Taccone; Andrew A Udy; Jean-Louis Vincent; Frédérique Jacobs; Jeffrey Lipman
Journal:  Antimicrob Agents Chemother       Date:  2011-03-14       Impact factor: 5.191

10.  Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock.

Authors:  Fabio Silvio Taccone; Pierre-François Laterre; Thierry Dugernier; Herbert Spapen; Isabelle Delattre; Xavier Wittebole; Daniel De Backer; Brice Layeux; Pierre Wallemacq; Jean-Louis Vincent; Frédérique Jacobs
Journal:  Crit Care       Date:  2010-07-01       Impact factor: 9.097
View more
  6 in total

1.  Strategies to reduce curative antibiotic therapy in intensive care units (adult and paediatric).

Authors:  Cédric Bretonnière; Marc Leone; Christophe Milési; Bernard Allaouchiche; Laurence Armand-Lefevre; Olivier Baldesi; Lila Bouadma; Dominique Decré; Samy Figueiredo; Rémy Gauzit; Benoît Guery; Nicolas Joram; Boris Jung; Sigismond Lasocki; Alain Lepape; Fabrice Lesage; Olivier Pajot; François Philippart; Bertrand Souweine; Pierre Tattevin; Jean-François Timsit; Renaud Vialet; Jean Ralph Zahar; Benoît Misset; Jean-Pierre Bedos
Journal:  Intensive Care Med       Date:  2015-06-03       Impact factor: 17.440

2.  Therapeutic drug monitoring-based dose optimisation of piperacillin and meropenem: a randomised controlled trial.

Authors:  Jan J De Waele; S Carrette; M Carlier; V Stove; J Boelens; G Claeys; I Leroux-Roels; E Hoste; P Depuydt; J Decruyenaere; A G Verstraete
Journal:  Intensive Care Med       Date:  2013-12-20       Impact factor: 17.440

3.  Initial dosing of intermittent vancomycin in adults: estimation of dosing interval in relation to dose and renal function.

Authors:  Martin Šíma; Jan Hartinger; Tomáš Grus; Ondřej Slanař
Journal:  Eur J Hosp Pharm       Date:  2019-08-07

4.  Evaluation of a protocol for vancomycin administration in critically patients with and without kidney dysfunction.

Authors:  Savino Spadaro; Angela Berselli; Alberto Fogagnolo; Maurizia Capuzzo; Riccardo Ragazzi; Elisabetta Marangoni; Sara Bertacchini; Carlo Alberto Volta
Journal:  BMC Anesthesiol       Date:  2015-06-27       Impact factor: 2.217

5.  Tigecycline use in critically ill patients: a multicentre prospective observational study in the intensive care setting.

Authors:  Philippe Montravers; Hervé Dupont; Jean-Pierre Bedos; Philippe Bret
Journal:  Intensive Care Med       Date:  2014-05-29       Impact factor: 17.440

6.  Screening of patients with augmented renal clearance in ICU: taking into account the CKD-EPI equation, the age, and the cause of admission.

Authors:  Stéphanie Ruiz; Vincent Minville; Karim Asehnoune; Marie Virtos; Bernard Georges; Olivier Fourcade; Jean-Marie Conil
Journal:  Ann Intensive Care       Date:  2015-12-14       Impact factor: 6.925
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.